期刊文献+

产金属酶铜绿假单胞菌的检测及耐药现状调查 被引量:2

Investigation on Detection and Antimicrobial-Resistant in Metallo-β-lactamase of Pseudomonas Aaeruginose
原文传递
导出
摘要 目的:研究临床中分离的耐亚胺培南铜绿假单胞菌的产金属酶的检测及耐药现状,为合理选择抗生素提供理论依据。方法:采用EDTA纸片复合法和E-test法分别筛选产金属β-内酰胺酶菌株,同时用PCR法检测blaIMP-1和blaVIM-2耐药基因,用MIC法测定产金属β-内酰胺酶菌株对8种常用抗菌药物的敏感度。结果:30株耐亚胺培南铜绿假单胞菌ED-TA纸片复合法筛选9株产金属酶菌株;E-test法筛选6株产金属酶菌株;PCR法仅检测到1株blaIMP-1和3株blaVIM-2耐药基因。产金属酶菌株呈多重耐药,尤其是PCR法产金属酶菌株耐药呈现为高水平耐药;阿米卡星抗菌活性最好,其次为环丙沙星。结论:金属酶是铜绿假单胞菌对亚胺培南耐药的原因之一,我院临床分离铜绿假单胞菌中部分携带金属酶,该酶导致该菌对碳青霉烯类耐药。 Objective:To study the detection method and the production of metallo-β-lactamase in imipenem-resistant Pseudomonas aeruginose for the reasonable selection of antibiotics.Methods:The phenotype of Metallo-β-lactamase were screened by EDTA-IMP disk diffusion method and E-test method.Molecular screening for Metallo-β-lactamase(blaIMP-1,blaVIM-2) were amplified by PCR method.The metallo-βlactamase-producing strains to 8 antibiotics was tested by MIC method.Results:Nine of 30 imipenem-resistant Pseudomonas aerug...
出处 《中国误诊学杂志》 CAS 2009年第3期505-508,共4页 Chinese Journal of Misdiagnostics
关键词 假单胞菌 铜绿/分离和提纯/药物作用 金属蛋白质类 抗药性 微生物 Pseudomonas aeruginosa/isolation & purification/drug effects Metalloproteins Drug Resistance Microbial
  • 相关文献

参考文献2

二级参考文献13

  • 1[1]CDC, National Nosocomial Infections Surveillance(NNIS) System report, Data summary from October 1986-April 1998; issyed June 1998[J]. Am J Infect Control, 1998,26: 522-533
  • 2[2]Gales AC, Jones RN, Turnidge J, et al. Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999[J].Clin Infect Dis,2001,32(Suppl 2): 146-155
  • 3[3]Harris AD, Smith D, Johnson JA, et al. Risk factors for imipenem-resistant pseudomonas aeruginosa among hospitalized patients [J]. Clin Infect Dis, 2002,34: 340-345
  • 4[4]Busher KH, Cullmann W, Dick W, et al. Imipenem resistance in pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein[J]. Antimicrob Agents Chemother,1987,31 : 703-708
  • 5[5]Pai H, Kim J, Kim J, et al. Carbapenem resistance mechanisms in pseudomonas aeruginosa clinical isolates [J]. Antimicrob agents chemother,2001,45:480-484
  • 6[4]Hirakata Y, Izumikawa K, Yamaguchi K, et al.Rapid detection and evolution of clinical characteristics of emerging multiple-drug-resistant Gram-negative rods carrying the metallo-β-lactamase gene blaIMP[J]. Antimicrob Agents Chemother, 1998, 42: 2006-2011.
  • 7[5]Arakawa Y, Shibata N, Shibayama K, et al. Convenient test for screening metallo-β-lactamase-producing Gram-negative bacteria by using thiol compounds[J]. J Clin Microbiol, 2000, 38(1): 40-43.
  • 8[6]National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard[S]. Fifth edition. Wayne Pennsylvania National Committee for Clinical Laboratory Standards. 2001.
  • 9[7]Saino Y, Kobayash F, Inoue M, et al. Purification and properties of inducible penicillin-beta-lactamase isolates from Pseudomonas maltophilia[J]. Antimicrob Agents Chemother, 1982, 22: 564-570.
  • 10[8]Senda K, Arakawa Y, Nakashima K, et al. Multifocal outbreaks of metallo-β-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum β-lactams, including carbapenems[J]. Antimicrob Agents Chemother, 1996, 40(2): 349-353.

共引文献143

同被引文献23

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部